Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Larry Flanagan

Vascular Surgery Bangor, ME Medical Doctor

NPI 1336174689 CMS profile 241607

489 State St, Vascular Care Of Maine, Bangor, ME 04401

Open in the dashboard

General payments

$7,957

102 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$8,200 paid to institutions, not to them · program years 2019–2023

Through program year 2025, Larry Flanagan of Bangor, ME is reported in the CMS Open Payments database as having received $7,957 across 102 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $8,200 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 62nd percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $137 1
2024 General $424 4
2023 General $719 10
2022 General $2,887 27
2021 General $1,012 19
2020 General $669 11
2019 General $2,109 30

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Larry Flanagan
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Larry Flanagan were reported at $137. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Larry Flanagan Vascular Surgery median Middle half National median
2019 $2,109 $796 $226–$2,363 $163
2020 $669 $348 $118–$1,110 $114
2021 $1,012 $471 $158–$1,421 $132
2022 $2,887 $725 $222–$2,183 $149
2023 $719 $836 $257–$2,440 $160
2024 $424 $909 $252–$2,619 $164
2025 $137 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. W. L. Gore & Associates, Inc. $2,953 22 payments
  2. Boston Scientific Corporation $1,545 17 payments
  3. Silk Road Medical, Inc. $1,418 17 payments
  4. Cook Medical LLC $995 24 payments
  5. Cardiovascular Systems Inc. $491 7 payments
  6. Shockwave Medical, Inc $193 3 payments
  7. Penumbra, Inc. $161 10 payments
  8. Asahi Intecc USA, Inc. $102 1 payment
  9. Endologix, Inc. $99 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $6,403 98 payments
  2. Travel and Lodging $1,555 4 payments
Products named General payments · program years 2019–2025
  1. GORE TAG Thoracic Endoprosthesis $1,785 6 payments
  2. ENROUTE Transcarotid Stent $972 12 payments
  3. ENROUTE Transcarotid Neuroprotection System Cardiology/Vascular Diseases $972 12 payments
  4. ENHANCE Transcarotid Peripheral Access Kit Cardiology/Vascular Diseases $606 8 payments
  5. ENROUTE .014 Guidewire $606 8 payments
  6. Cook Medical AAA $606 16 payments
  7. ENROUTE 0.014 Guidewire $446 5 payments
  8. ENROUTE Transcarotid Stent System $446 5 payments
  9. ENROUTE Transcarotid Neuroprotection System Carotid Artery Disease $446 5 payments
  10. ENHANCE Transcarotid Peripheral Access Kit Carotid Artery Disease $446 5 payments
  11. Other $3,983 61 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

102 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record